NIPT
Non-invasive prenatal test is a state-of-the-art, risk free method for DNA-screening of the unborn fetus in maternal blood.
Contact usDescription
Benefits
Process
Blood samples are collected authorized iLab partner. Samples are sent to the Lab for analysis. Complete and accurate results are normally reported within 10 days.
How it works
Vanadis® NIPT is the only screening assay that targets specific chromosomes without using PCR amplification. Instead, target fragments are captured into circular DNA objects that are replicated to form DNA bundles that are labeled for counting. No replication of DNA is done.
Vanadis® NIPT simplifies the complexity of non-invasive prenatal testing and making it accessible to more women. This pioneering cell-free DNA (cfDNA) technology eliminates PCR amplification and gene sequencing, which is the key to its high performance.
The method's high precision means that reliable results can be obtained despite very low levels of fetal DNA fraction.